CLP-3094 is a BF3-Directed Androgen Receptor Inhibitor and GPR142 Antagonist
The androgen receptor (AR) plays a pivotal role in the development of the prostate gland. It also has relations with the occurrence and progression of prostate cancer (PCa). AR is…